NCT06968988
- Conditions
- Metastatic Soft-tissue Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Clinical trial condition
Metastatic Soft-tissue Sarcoma
Explore clinical trials studying Metastatic Soft-tissue Sarcoma. Study availability and eligibility vary by location and protocol.
7 public trials
2 recruiting studies
Metastatic Soft-tissue Sarcoma trial results
NCT06474676
- Conditions
- Metastatic Soft-tissue Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT03022448
- Conditions
- Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Neoplasms, +3 more
- Locations
-
- Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
- Medizinische Universität Wien Vienna, Austria
- HELIOS Klinikum Bad Saarow Bad Saarow, Germany
- HELIOS Klinikum Berlin Buch Berlin, Germany
Active, Not Recruiting
Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
NCT04874311
- Conditions
- Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Neoplasm Metastasis, +9 more
- Locations
-
- Institut Bergonie Bordeaux, France
- Centre Georges François Leclerc Dijon, France
- Centre Léon Bérard Lyon, France
- Institut Paoli Calmette Marseille, France
Active, Not Recruiting
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
NCT05180695
- Conditions
- Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Neoplasms, +3 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Centre Léon Bérard Lyon, France
- Institut Paoli-Calmettes Marseille, France
- Institut Claudius Regaud Toulouse, France
Active, Not Recruiting
Lurbinectedin + Doxorubicin In Leiomyosarcoma
NCT05099666
- Conditions
- Advanced Leiomyosarcoma, Advanced Soft-tissue Sarcoma, Leiomyosarcoma Metastatic, +5 more
- Locations
-
- Mayo Arizona Phoenix, Arizona, United States
- Mayo Jacksonville Jacksonville, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
NCT04551430
- Conditions
- Metastatic Soft-tissue Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Colorado Aurora, Colorado, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Abramson Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States